Correction: Hydroxysafflor yellow a attenuates sepsis-induced intestinal barrier dysfunction by modulating Bcl-2/SOD2-mediated mitochondrial apoptosis
Year: 2026
Type: erratum
Abstract: Correction on: Fei J, Xu C, Chen C, Chen Q, Wu Z, Wang Y, Bao D and Shao S (2026) Hydroxysafflor yellow A attenuates sepsis-induced intestinal barrier dysfunction by modulating Bcl-2/SOD2-mediated mitochondrial apoptosis. Front. Pharmacol. 17:1728183. doi: 10.3389/fphar.2026.1728183 There was a mistake in figure [6C] as published. [When preparing the TUNEL in Fig. 6C, the TUNEL of in Fig. 4C was used as the paradigm. However, the TUNEL of 4C was forgotten to be replaced with that of TUNEL in Fig. 6C]. The corrected figure [6C] appears below.The original version of this article has been updated.license and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, to follow any citation instructions requested by third-party rights holders, and cover any supplementary charges.for a reason not seen here, please contact the journal's editorial office.
Source: Frontiers in Pharmacology
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7133754729
Cites:
Cited by:
Related to: